Page 47 - Central Drug Authority Annual Report 2021
P. 47
DEPARTMENT KEY ACTIVITY KEY ACTIVITY ACHIEVEMENTS MTSF CONFERENCE
DELIVERABLE CONTRIBUTION OUT- RESOLUTION
TO OUTCOME COMES NUMBER
6$36 7KH DQDO\VLV DQG 7KH LGHQWLˉFDWLRQ RI 6HFXULW\ RI GLVFRYHUHG
SURYLVLRQ RI Clandestine Drug $FWLYLW\ &'/ȠV GLVDEOHG
intelligence products /DERUDWRULHV &'/ȠV Reduction of
to enhance the GXULQJ SURMHFW GULYHQ power and
intelligence picture LQYHVWLJDWLRQV reach of
DQG HIIHFWLYHQHVV RI day-to-day policing RUJDQL]HG
ODZ HQIRUFHPHQW DFWLYLWLHV RU LQWHOOLJHQFH FULPH
Dismantling of
&'/V DQG WKH GLVDEOLQJ RI
WKH &'/ WR SUHYHQW WR
PDQXIDFWXULQJ RI GUXJV
6$36 7KH DQDO\VLV DQG 'LVPDQWOLQJ RI &'/V DQG 6HFXULW\ RSHUDWLRQV
SURYLVLRQ RI the disabling $FWLYLW\ FRQGXFWHG
intelligence products RI WKH &'/V WR SUHYHQW Reduction of
to enhance the the manufacturing of power and 60 arrests
intelligence picture GUXJV reach of
DQG HIIHFWLYHQHVV RI RUJDQL]HG FULPH
ODZ HQIRUFHPHQW 2SHQ D &ULPH
$GPLQLVWUDWLRQ 6\VWHP
6$36 7KH DQDO\VLV DQG &$6 HQTXLU\ 7DVN 7HDP
SURYLVLRQ RI RI LQIRUPHUV DQG &O
intelligence products
to enhance the &RQGXFW REVHUYDWLRQ
intelligence picture and monitoring of
DQG HIIHFWLYHQHVV RI suspects to identify
ODZ HQIRUFHPHQW VXVSHFW GUXJ GHDOHUV
,GHQWLˉFDWLRQ RI VXVSHFWV
ZKR DUH LQYROYHG LQ WKH
manufacturing of drugs
DW &'/V DQG DUUHVWLQJ
WKHVH VXVSHFWV
,GHQWLˉFDWLRQ DQG WUDFH
VXVSHFWVWKDW DUHLQYROYHG
8WLOLVH ZLWQHVVHV DQG
rental contracts to link
WKHP WR WKH FULPH VFHQH
2EWDLQ ZDUUDQWV RI
DUUHVW
6$36 7KH DQDO\VLV DQG 6HL]XUH RI GUXJV GXULQJ 6HFXULW\ 9DOXH RI 2SHUDWLRQ
SURYLVLRQ RI GLVPDQWOLQJ RI &'/ $FWLYLW\ 5 PLOOLRQ
intelligence products Reduction of
to enhance the power and
intelligence picture reach of
DQG HIIHFWLYHQHVV RI RUJDQL]HG FULPH
ODZ HQIRUFHPHQW
Enhance operational 0RQLWRULQJ RI FKHPLFDO 6RFLDO $FWLYLW\ $FKLHYHG
coordination at all FRPSDQLHV 5HFHLYH 6WUHQJWKHQHG
OHYHOV LPSRUW QRWLˉFDWLRQV RQ Partnerships
RQ OLQH V\VWHP 9HULI\
order - Process import
SHUPLW
Respond to country and
company
^FRPSHWHQW DXWKRULW\
Annual Report 2020/2021 Central Drug Authority 45